Fatty Acid Binding Protein 5 is a Novel Target in Multiple Myeloma

ABSTRACT: To identify protein changes in human myeloma cancer cells resulting from FABP inhibition, we treated GFP+/Luc+MM.1S cells with the single inhibitors (50 µM BMS309405 or 50 µM SBFI-26) or the combination (50 µM of each) for 48 hour, isolated total cell proteins, and performed a mass spectrometry-based proteomic analysis.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Blood Plasma, Plasma Cell

DISEASE(S): Multiple Myeloma

SUBMITTER: Carlos Gartner  

LAB HEAD: Calvin Vary

PROVIDER: PXD032829 | Pride | 2023-01-12

REPOSITORIES: Pride